YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Image source: The Motley Fool. DATE Wednesday, Aug. 12, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer - Eric SchlorffSenior Vice President of Commercial and Business Operations - Tim VaracekChief Medical Officer - Kevin Ch…
Earnings Call Insights: SeaStar Medical Holding Corporation (ICU) Q2 2026 MANAGEMENT VIEW * "We are very pleased with our progress this quarter" and "Our pediatric AKI market penetration and continued strong QUELIMMUNE revenue growth bodes…
DENVER, Aug. 06, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss o…
Sponsors educational summit of leading pediatric AKI health care experts Announces best practices webinar to further advance new treatment options DENVER, July 14, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU),…
(RTTNews) - Today's leading biotech gainers include Can-Fite, following an update from its pancreatic cancer study; SeaStar Medical, driven by improving quarter-over-quarter revenue for its flagship product; and Elicio, which has refined i…
On Wednesday, SeaStar Medical Holding (NASDAQ:ICU) discussed first-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga APIs. For real-time access to our e…
Added 7 top-rated children’s hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing first quarter revenue 69% versus first quarter 2025 revenue Advanced enrollment in the NEUTRALIZE-AKI pivotal clinical tria…
Companies Reporting Before The Bell • Similarweb (NYSE:SMWB) is estimated to report quarterly earnings at $0.01 per share on revenue of $72.97 million. • Dominari Holdings (NASDAQ:DOMH) is projected to report earnings for its first quarter…
(RTTNews) - SeaStar Medical Holding Corporation (ICU) showcased new positive real-world data from its QUELIMMUNE SAVE Registry, along with new mechanistic insights into its Selective Cytopheretic Device therapy, at the AKI & CRRT 2026 conf…
(RTTNews) - SeaStar Medical Holding Corporation, (ICU) a commercial-stage medical device company reported fourth quarter results reflecting a narrower net loss backed by revenue growth. In addition, it also provided business updates on its…
DENVER, March 18, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of l…
Virtual Investor Conferences NEW YORK, March 13, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that presentations from the Life Sciences Virtual Investor Forum, h…
NEW YORK, March 13, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that presentations from the Life Sciences Virtual Investor Forum, held March 11th – 12th, are no…
Virtual Investor Conferences Company Executives Share Strategic Vision and Engage with Investors Live at VirtualInvestorConferences.com NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary inve…
DENVER, March 09, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of l…
NASDAQ:ICU David Bautz, PhD: Hi, and welcome to another edition of our CEO Chats. My name is David Bautz, Senior Biotech Analyst with Zacks Small Cap Research. Joining me today is Mr. Eric Schlorff. He's the CEO of SeaStar Medical Holding…
SeaStar Medical DENVER, Dec. 23, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and pote…
FDA lowers surveillance requirement to 50 patients from 300 patients in original HDE approval based on assessment of first 21 SAVE Surveillance Registry patients Compelling efficacy data to date along with completion of registry expected t…
(RTTNews) - Several small- and mid-cap biotech and healthcare names posted notable gains in Tuesday's after-hours trading, with investor attention drawn to corporate updates and recent financing developments. SeaStar Medical Holding Corp.…
(RTTNews) - SeaStar Medical Holding Corporation (ICU), a commercial-stage healthcare company focused on therapies for critically ill patients facing organ failure, is scheduled to present at the NobleCon21 Investor Conference in Boca Raton…
DENVER, Nov. 20, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of li…
DENVER, Nov. 17, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of li…
Image source: The Motley Fool. Date Nov. 13, 2025 at 4:30 p.m. ET Call participants Chief Executive Officer — Eric Schlorff Chief Commercial Officer — Tim Varacek Chief Medical Officer — Kevin Chung Controller — Brad Town Investor Relation…
Business highlights include: Three new top-rated children’s hospitals adopt QUELIMMUNE therapy for ultra-rare pediatric Acute Kidney Injury (AKI)Commercial use of QUELIMMUNE therapy demonstrates positive survival results as reported from t…
DENVER, Nov. 05, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of li…
Data show results consistent with clinical trial experience A high level of safety – no device-related adverse events Strong survival data extending to 90 days DENVER, Sept. 29, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation…
(RTTNews) - SeaStar Medical Holding Corporation (ICU), a commercial-stage healthcare company, yesterday announced that the independent Data Safety Monitoring Review Board (DSMB) has recommended the continuation of the NEUTRALIZE-AKI pivota…
Independent DSMB reports zero device-related safety issues Supports potential clinical benefit Trial sample size re-estimated to strengthen statistical power DENVER, Sept. 24, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (N…
DENVER, Sept. 23, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company, announced today that preliminary results from the SAVE Surveillance Registry will be presented by SeaStar…
DENVER, Sept. 04, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of l…
DENVER, Sept. 02, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of l…
* SeaStar Medical Holding press release [https://seekingalpha.com/pr/20200176-seastar-medical-reports-second-quarter-2025-financial-results-and-provides-business-updates] (NASDAQ:ICU [https://seekingalpha.com/symbol/ICU]): Q2 GAAP EPS of -…
Business highlights include: Adult NEUTRALIZE-AKI trial enrolls 31 new patients, now over 60% enrolledThree new top-rated children’s hospitals adopt QUELIMMUNE therapy for ultra-rare pediatric Acute Kidney Injury (AKI)Positive survival res…
* SeaStar Medical (NASDAQ:ICU [https://seekingalpha.com/symbol/ICU]) filed to sell 10.92M shares of common stock for holders. * This preliminary prospectus is not an offer to sell. * Filing [https://seekingalpha.com/filing/10286537] MORE O…
DENVER, Aug. 07, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of li…
Trial now over 60% enrolled with 125 of 200 anticipated patients Recent new site activation brings total clinical trial sites to 16 Interim analysis of first 100 patients remains on track for 3Q 2025 DENVER, Aug. 06, 2025 (GLOBE NEWSWIRE)…